抗カテプシンBの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE1824)
◆英語タイトル:Global Anti-Cathepsin B Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE1824
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、抗カテプシンBの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(一次抗体、タンパク質&ペプチド、溶解物)、用途別市場規模(がん、外傷性脳損傷、エボラ感染、排卵誘発剤、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・抗カテプシンBの市場動向
・企業の競争状況、市場シェア
・抗カテプシンBの種類別市場規模(一次抗体、タンパク質&ペプチド、溶解物)
・抗カテプシンBの用途別市場規模(がん、外傷性脳損傷、エボラ感染、排卵誘発剤、その他)
・抗カテプシンBの北米市場規模2016-2027(アメリカ、カナダ)
・抗カテプシンBの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・抗カテプシンBのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・抗カテプシンBの中南米市場規模2016-2027(メキシコ、ブラジル)
・抗カテプシンBの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Merck KGaA、Bio-Techne, BioVision Inc.、Santa Cruz Biotechnology, Inc.、MedChemExpress、BioCat GmbH、ApexBio Technology、Cayman Chemical、Selleck Chemicals、BOC Sciences、AG Scientific、Virobay Inc.、Abcam Plc)
・結論
【レポートの概要】

Cathepsin B belongs to a family of lysosomal cysteine proteases. It plays an important role in intracellular proteolysis. In humans, Cathepsin B is encoded by the CTSB gene. Anti-Cathepsin B antibody is used to treat cancers, traumatic brain injuries, Ebola infection, and fertility issues.

Market Analysis and Insights: Global Anti-Cathepsin B Market
The global Anti-Cathepsin B market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Cathepsin B market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Cathepsin B market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Cathepsin B market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Cathepsin B market.

Global Anti-Cathepsin B Scope and Market Size
Anti-Cathepsin B market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Cathepsin B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Primary Antibodies
Proteins and Peptides
Lysates

Segment by Application
Cancer
Traumatic Brain Injury
Ebola Infection
Fertility Treatment
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck KGaA
Bio-Techne, BioVision Inc.
Santa Cruz Biotechnology, Inc.
MedChemExpress
BioCat GmbH
ApexBio Technology
Cayman Chemical
Selleck Chemicals
BOC Sciences
AG Scientific
Virobay Inc.
Abcam Plc

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Cathepsin B Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Primary Antibodies
1.2.3 Proteins and Peptides
1.2.4 Lysates
1.3 Market by Application
1.3.1 Global Anti-Cathepsin B Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Traumatic Brain Injury
1.3.4 Ebola Infection
1.3.5 Fertility Treatment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-Cathepsin B Market Perspective (2016-2027)
2.2 Anti-Cathepsin B Growth Trends by Regions
2.2.1 Anti-Cathepsin B Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Cathepsin B Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Cathepsin B Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Cathepsin B Industry Dynamic
2.3.1 Anti-Cathepsin B Market Trends
2.3.2 Anti-Cathepsin B Market Drivers
2.3.3 Anti-Cathepsin B Market Challenges
2.3.4 Anti-Cathepsin B Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-Cathepsin B Players by Revenue
3.1.1 Global Top Anti-Cathepsin B Players by Revenue (2016-2021)
3.1.2 Global Anti-Cathepsin B Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Cathepsin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Cathepsin B Revenue
3.4 Global Anti-Cathepsin B Market Concentration Ratio
3.4.1 Global Anti-Cathepsin B Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Cathepsin B Revenue in 2020
3.5 Anti-Cathepsin B Key Players Head office and Area Served
3.6 Key Players Anti-Cathepsin B Product Solution and Service
3.7 Date of Enter into Anti-Cathepsin B Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Cathepsin B Breakdown Data by Type
4.1 Global Anti-Cathepsin B Historic Market Size by Type (2016-2021)
4.2 Global Anti-Cathepsin B Forecasted Market Size by Type (2022-2027)

5 Anti-Cathepsin B Breakdown Data by Application
5.1 Global Anti-Cathepsin B Historic Market Size by Application (2016-2021)
5.2 Global Anti-Cathepsin B Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-Cathepsin B Market Size (2016-2027)
6.2 North America Anti-Cathepsin B Market Size by Type
6.2.1 North America Anti-Cathepsin B Market Size by Type (2016-2021)
6.2.2 North America Anti-Cathepsin B Market Size by Type (2022-2027)
6.2.3 North America Anti-Cathepsin B Market Size by Type (2016-2027)
6.3 North America Anti-Cathepsin B Market Size by Application
6.3.1 North America Anti-Cathepsin B Market Size by Application (2016-2021)
6.3.2 North America Anti-Cathepsin B Market Size by Application (2022-2027)
6.3.3 North America Anti-Cathepsin B Market Size by Application (2016-2027)
6.4 North America Anti-Cathepsin B Market Size by Country
6.4.1 North America Anti-Cathepsin B Market Size by Country (2016-2021)
6.4.2 North America Anti-Cathepsin B Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-Cathepsin B Market Size (2016-2027)
7.2 Europe Anti-Cathepsin B Market Size by Type
7.2.1 Europe Anti-Cathepsin B Market Size by Type (2016-2021)
7.2.2 Europe Anti-Cathepsin B Market Size by Type (2022-2027)
7.2.3 Europe Anti-Cathepsin B Market Size by Type (2016-2027)
7.3 Europe Anti-Cathepsin B Market Size by Application
7.3.1 Europe Anti-Cathepsin B Market Size by Application (2016-2021)
7.3.2 Europe Anti-Cathepsin B Market Size by Application (2022-2027)
7.3.3 Europe Anti-Cathepsin B Market Size by Application (2016-2027)
7.4 Europe Anti-Cathepsin B Market Size by Country
7.4.1 Europe Anti-Cathepsin B Market Size by Country (2016-2021)
7.4.2 Europe Anti-Cathepsin B Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-Cathepsin B Market Size (2016-2027)
8.2 Asia-Pacific Anti-Cathepsin B Market Size by Type
8.2.1 Asia-Pacific Anti-Cathepsin B Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Cathepsin B Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Cathepsin B Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Cathepsin B Market Size by Application
8.3.1 Asia-Pacific Anti-Cathepsin B Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Cathepsin B Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Cathepsin B Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Cathepsin B Market Size by Region
8.4.1 Asia-Pacific Anti-Cathepsin B Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Cathepsin B Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-Cathepsin B Market Size (2016-2027)
9.2 Latin America Anti-Cathepsin B Market Size by Type
9.2.1 Latin America Anti-Cathepsin B Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Cathepsin B Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Cathepsin B Market Size by Type (2016-2027)
9.3 Latin America Anti-Cathepsin B Market Size by Application
9.3.1 Latin America Anti-Cathepsin B Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Cathepsin B Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Cathepsin B Market Size by Application (2016-2027)
9.4 Latin America Anti-Cathepsin B Market Size by Country
9.4.1 Latin America Anti-Cathepsin B Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Cathepsin B Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-Cathepsin B Market Size (2016-2027)
10.2 Middle East & Africa Anti-Cathepsin B Market Size by Type
10.2.1 Middle East & Africa Anti-Cathepsin B Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Cathepsin B Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Cathepsin B Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Cathepsin B Market Size by Application
10.3.1 Middle East & Africa Anti-Cathepsin B Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Cathepsin B Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Cathepsin B Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Cathepsin B Market Size by Country
10.4.1 Middle East & Africa Anti-Cathepsin B Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Cathepsin B Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Anti-Cathepsin B Introduction
11.1.4 Merck KGaA Revenue in Anti-Cathepsin B Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Bio-Techne, BioVision Inc.
11.2.1 Bio-Techne, BioVision Inc. Company Details
11.2.2 Bio-Techne, BioVision Inc. Business Overview
11.2.3 Bio-Techne, BioVision Inc. Anti-Cathepsin B Introduction
11.2.4 Bio-Techne, BioVision Inc. Revenue in Anti-Cathepsin B Business (2016-2021)
11.2.5 Bio-Techne, BioVision Inc. Recent Development
11.3 Santa Cruz Biotechnology, Inc.
11.3.1 Santa Cruz Biotechnology, Inc. Company Details
11.3.2 Santa Cruz Biotechnology, Inc. Business Overview
11.3.3 Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Introduction
11.3.4 Santa Cruz Biotechnology, Inc. Revenue in Anti-Cathepsin B Business (2016-2021)
11.3.5 Santa Cruz Biotechnology, Inc. Recent Development
11.4 MedChemExpress
11.4.1 MedChemExpress Company Details
11.4.2 MedChemExpress Business Overview
11.4.3 MedChemExpress Anti-Cathepsin B Introduction
11.4.4 MedChemExpress Revenue in Anti-Cathepsin B Business (2016-2021)
11.4.5 MedChemExpress Recent Development
11.5 BioCat GmbH
11.5.1 BioCat GmbH Company Details
11.5.2 BioCat GmbH Business Overview
11.5.3 BioCat GmbH Anti-Cathepsin B Introduction
11.5.4 BioCat GmbH Revenue in Anti-Cathepsin B Business (2016-2021)
11.5.5 BioCat GmbH Recent Development
11.6 ApexBio Technology
11.6.1 ApexBio Technology Company Details
11.6.2 ApexBio Technology Business Overview
11.6.3 ApexBio Technology Anti-Cathepsin B Introduction
11.6.4 ApexBio Technology Revenue in Anti-Cathepsin B Business (2016-2021)
11.6.5 ApexBio Technology Recent Development
11.7 Cayman Chemical
11.7.1 Cayman Chemical Company Details
11.7.2 Cayman Chemical Business Overview
11.7.3 Cayman Chemical Anti-Cathepsin B Introduction
11.7.4 Cayman Chemical Revenue in Anti-Cathepsin B Business (2016-2021)
11.7.5 Cayman Chemical Recent Development
11.8 Selleck Chemicals
11.8.1 Selleck Chemicals Company Details
11.8.2 Selleck Chemicals Business Overview
11.8.3 Selleck Chemicals Anti-Cathepsin B Introduction
11.8.4 Selleck Chemicals Revenue in Anti-Cathepsin B Business (2016-2021)
11.8.5 Selleck Chemicals Recent Development
11.9 BOC Sciences
11.9.1 BOC Sciences Company Details
11.9.2 BOC Sciences Business Overview
11.9.3 BOC Sciences Anti-Cathepsin B Introduction
11.9.4 BOC Sciences Revenue in Anti-Cathepsin B Business (2016-2021)
11.9.5 BOC Sciences Recent Development
11.10 AG Scientific
11.10.1 AG Scientific Company Details
11.10.2 AG Scientific Business Overview
11.10.3 AG Scientific Anti-Cathepsin B Introduction
11.10.4 AG Scientific Revenue in Anti-Cathepsin B Business (2016-2021)
11.10.5 AG Scientific Recent Development
11.11 Virobay Inc.
11.11.1 Virobay Inc. Company Details
11.11.2 Virobay Inc. Business Overview
11.11.3 Virobay Inc. Anti-Cathepsin B Introduction
11.11.4 Virobay Inc. Revenue in Anti-Cathepsin B Business (2016-2021)
11.11.5 Virobay Inc. Recent Development
11.12 Abcam Plc
11.12.1 Abcam Plc Company Details
11.12.2 Abcam Plc Business Overview
11.12.3 Abcam Plc Anti-Cathepsin B Introduction
11.12.4 Abcam Plc Revenue in Anti-Cathepsin B Business (2016-2021)
11.12.5 Abcam Plc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗カテプシンBの世界市場規模・現状・予測2021年-2027年(Global Anti-Cathepsin B Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。